Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti Viral Treatment in Mild Cognitive Impairment

NCT04710030 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT04710030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04710030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti Viral Treatment in Mild Cognitive Impairment
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 2
Overall status
Completed
Start date
February 1, 2021
Completion date
December 23, 2024
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

herpes simplex 1, herpes simplex 2, mild cognitive impairment